ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and “Inconsistent” Execution

SAN FRANCISCO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a series of disclosures that calls into question the reasonable basis for the company’s previously expressed “high confidence” in its 2025 revenue targets. The firm urges investors who suffered significant losses to submit your ZBH losses now and visit Hagens Berman’s case page to view our latest investigation summary: www.hbsslaw.com/cases/z ...